SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Small Cap Foreign Biotech
An SI Board Since January 2000
Posts SubjectMarks Bans
363 30 0
Emcee:  RWReeves Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
213Looking for clues that some other countrie' biotechs might be considered saftuck-9/17/2001
212Antisoma, CeNeS, GW from FTMW: Antisoma signs in-licensing deal Xenova starts Pkeokalani'nui-9/10/2001
211Xenova Group plc: Anti-Nicotine Addiction Vaccine TA-NIC Enters Phase I Trials nigel bates-9/10/2001
210By Ben Hirschler LONDON, Sept 4 (Reuters) - Britain's Pharmagene Plc (LSE: Pnigel bates-9/5/2001
209Protherics gets FDA approval for digoxin treatment LONDON, Sept 3 (Reuters) - Bnigel bates-9/3/2001
208[30 August 2001, London, UK] – Antisoma plc, the UK-based biopharmaceutical compnigel bates-8/31/2001
207MELBOURNE, Australia and BOSTON, Aug. 30 /PRNewswire/ -- Prana Biotechnology Limnigel bates-8/30/2001
206LONDON (Reuters) (By Mark Potter) - Uncertainty over the future of its main backnigel bates-8/17/2001
205SLOUGH, England, Aug. 13 /PRNewswire/ -- Xenova Group plc (Nasdaq: XNVA; London nigel bates-8/14/2001
204Nice call, Ben - QLT expands pipeline with acquisition of late-stage compound fnigel bates-8/13/2001
203By Ben Hirschler, European Pharmaceuticals Correspondent LONDON (Reuters) - Biotnigel bates-8/13/2001
202Cambridge, UK – 1 August 2001 – Acambis plc (“Acambis”) (LSE: ACM, NASDAQ: ACAM)nigel bates-8/6/2001
201Protherics results out yesterday, & available for download at - protherics.cnigel bates-7/20/2001
200Protherics (PTI.L) might be worth a look, after selling a bit of themselves to Tnigel bates-7/13/2001
199PPL Therapeutics (LSE: PTH.L - news) , the U.K. biotech company responsible for nigel bates-7/12/2001
198LONDON (Reuters) - Biotechnology company Xenova Group (LSE: XEN.L - news) has senigel bates-6/21/2001
197BURLINGAME, Calif., June 20 /PRNewswire/ -- ReNeuron Holdings plc (ReN.L), a leanigel bates-6/20/2001
196Let's hope they're not the UK's version of Coulter... As for the UKnigel bates-6/7/2001
195Nig, read it too this morning, I think this is very very bad for the stock. dedalroi-6/6/2001
194LONDON (Reuters) - Antisoma (LSE: ASM.L - news) has said there will be an 18-monnigel bates-6/6/2001
193Noted, Nigel. Thanks. EOMkeokalani'nui-5/30/2001
192Noting Wilder's interest in Adprotech, Prelude Trust results - uk.biz.yahoonigel bates-5/30/2001
191By Saskia Wirth, FTMarketWatch.com   May 29, 2001   LONDON (FTMWnigel bates-5/29/2001
190May 29 (Reuters) - Bayer Corp. and PPL Therapeutics (LSE: PTH.L - news) said on nigel bates-5/29/2001
189Story in the weekend press that Cyclacel is very near to closing a £30m prinigel bates-5/20/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News